Hutch News

Stories tagged 'Clinical Research'

Dissolving implant could bring immunotherapy to solid tumors

A biopolymer sponge delivers cancer-shrinking T-cell therapy in preclinical study

April 24, 2017 | By Sabrina Richards / Fred Hutch News Service

A dissolving scaffold developed by Dr. Matthias Stephan delivers engineered anti-tumor immune cells to crowded masses of tumor cells and recruits the native immune system to mount a second-wave attack on the cancer.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

April 20, 2017

Dr. Glenda Gray among Time magazine’s ‘100 most influential’; Fred Hutch license plates coming soon; UW establishes Dr. Oliver W. Press Distinguished MSTP Alumnus Award; and Dr. Vivian Oehler receives ASH Bridge Grant for leukemia research.

View story >


Tiny tech reprograms immune cells to fight cancer

Nanoparticles turn immune cells into leukemia-fighting powerhouses while they’re still inside the body

April 17, 2017 | By Sabrina Richards / Fred Hutch News Service

Dr. Matthias Stephan has designed nanoparticles that have the potential to make cellular immunotherapy quicker, cheaper, easier to administer and more widely available, by carrying anti-cancer genes to immune cells still inside the body.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

April 6, 2017

Dr. Marie Bleakley receives innovator award for new leukemia immunotherapies; Dr. Anthony Rongvaux receives grant from Lupus Research Alliance; Drs. Benjamin Greer, Wui-Jin Koh win NCCN award.

View story >


Proteowhatnow? 6 questions with a proteomics expert

How a new technology could help identify the best cancer treatment for an individual patient

April 5, 2017 | by Susan Keown / Fred Hutch News Service

As an oncologist, Dr. Mandy Paulovich ran into an "ethical dilemma" when treating her patients. Since then, she's dedicated her career to proteomics in her quest to solve it.

View story >


Deploying an ancient defense to kill cancer

In a small sarcoma trial, signs of immune attack after injections of a bacteria-inspired drug

April 3, 2017 | By Susan Keown / Fred Hutch News Service

A small sarcoma trial showed signs of the immune system attacking cancer after injections of a bacteria-inspired drug.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.